Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Research & Development (2016 - 2025)

Historic Research & Development for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $45.9 million.

  • Wave Life Sciences' Research & Development rose 1135.28% to $45.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.6 million, marking a year-over-year increase of 1710.07%. This contributed to the annual value of $159.7 million for FY2024, which is 2282.38% up from last year.
  • As of Q3 2025, Wave Life Sciences' Research & Development stood at $45.9 million, which was up 1135.28% from $43.5 million recorded in Q2 2025.
  • Wave Life Sciences' Research & Development's 5-year high stood at $45.9 million during Q3 2025, with a 5-year trough of $25.8 million in Q4 2021.
  • Moreover, its 5-year median value for Research & Development was $33.3 million (2023), whereas its average is $34.6 million.
  • In the last 5 years, Wave Life Sciences' Research & Development tumbled by 1886.63% in 2021 and then surged by 3102.37% in 2024.
  • Wave Life Sciences' Research & Development (Quarter) stood at $25.8 million in 2021, then rose by 20.64% to $31.1 million in 2022, then rose by 9.64% to $34.1 million in 2023, then surged by 31.02% to $44.6 million in 2024, then grew by 2.75% to $45.9 million in 2025.
  • Its Research & Development was $45.9 million in Q3 2025, compared to $43.5 million in Q2 2025 and $40.6 million in Q1 2025.